BMEA
Price
$1.41
Change
+$0.02 (+1.44%)
Updated
Jan 16 closing price
Capitalization
99.69M
78 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.76
Change
-$0.06 (-1.57%)
Updated
Jan 16 closing price
Capitalization
209.06M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs VYGR

Header iconBMEA vs VYGR Comparison
Open Charts BMEA vs VYGRBanner chart's image
Biomea Fusion
Price$1.41
Change+$0.02 (+1.44%)
Volume$1.59M
Capitalization99.69M
Voyager Therapeutics
Price$3.76
Change-$0.06 (-1.57%)
Volume$569.62K
Capitalization209.06M
BMEA vs VYGR Comparison Chart in %
BMEA
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BMEA vs. VYGR commentary
Jan 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 19, 2026
Stock price -- (BMEA: $1.41 vs. VYGR: $3.76)
Brand notoriety: BMEA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 112% vs. VYGR: 117%
Market capitalization -- BMEA: $99.69M vs. VYGR: $209.06M
BMEA [@Biotechnology] is valued at $99.69M. VYGR’s [@Biotechnology] market capitalization is $209.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than VYGR.

Price Growth

BMEA (@Biotechnology) experienced а -0.70% price change this week, while VYGR (@Biotechnology) price change was -6.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

BMEA is expected to report earnings on Apr 06, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($209M) has a higher market cap than BMEA($99.7M). BMEA YTD gains are higher at: 13.710 vs. VYGR (-4.326). BMEA has higher annual earnings (EBITDA): -97.83M vs. VYGR (-136.19M). BMEA (46.6M) and VYGR (45.1M) have equal amount of cash in the bank . BMEA has less debt than VYGR: BMEA (6.88M) vs VYGR (38.4M). VYGR has higher revenues than BMEA: VYGR (31.3M) vs BMEA (0).
BMEAVYGRBMEA / VYGR
Capitalization99.7M209M48%
EBITDA-97.83M-136.19M72%
Gain YTD13.710-4.326-317%
P/E RatioN/A6.00-
Revenue031.3M-
Total Cash46.6M45.1M103%
Total Debt6.88M38.4M18%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEAVYGR
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 27 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRCLF5.00N/A
N/A
GrainCorp Ltd.
PCCWY6.95N/A
N/A
PCCW Limited
TNXXF131.00N/A
N/A
Talanx AG
EWSB9.04N/A
N/A
EWSB Bancorp, Inc.
NRSAF0.55-0.02
-4.09%
Norse Atlantic ASA

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with TCRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
+1.08%
TCRX - BMEA
39%
Loosely correlated
-0.88%
VYGR - BMEA
38%
Loosely correlated
-1.57%
AGEN - BMEA
36%
Loosely correlated
-9.24%
ZNTL - BMEA
36%
Loosely correlated
-6.33%
SYRE - BMEA
36%
Loosely correlated
+0.45%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with KURA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-1.57%
KURA - VYGR
55%
Loosely correlated
-5.05%
RGNX - VYGR
55%
Loosely correlated
-1.02%
XNCR - VYGR
54%
Loosely correlated
-3.18%
IMNM - VYGR
50%
Loosely correlated
-1.93%
CRSP - VYGR
49%
Loosely correlated
-1.29%
More